Pentagalloylglucose downregulates cofilin1 and inhibits HSV-1 infection

Antiviral Research

Volumn 89, Issue 1, 2011, Pages 98-108

  Pei, Ying ^a   Xiang, Yang Fei ^a   Chen, Jia Nan ^a   Lu, Chun Hua ^a   Hao, Jing ^b   Du, Qian ^a   lai, Chi choi ^a   Qu, Chang ^a   Li, Shen ^a   Ju, Huai Qiang ^a   Ren, Zhe ^a   Liu, Qiu Ying ^a   Xiong, Sheng ^a   Qian, Chui Wen ^a   Zeng, Fan Li ^a   Zhang, Pei Zhuo ^c   Yang, Chong Ren ^d   Zhang, Ying Jun ^d   Xu, Jun ^e   Kitazato, Kaio ^f   Wang, Yi Fei ^a   more..

^a JINAN UNIVERSITY   (China)

^b SOUTH CHINA INSTITUTE OF BOTANY   (China)

^c Shanghai GenePharma Co Ltd   (China)

^d KUNMING INSTITUTE OF BOTANY   (China)

^e SUN YAT SEN UNIVERSITY   (China)

^f NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Actin cytoskeleton; Cofilin1; Herpes simplex virus type 1; Pentagalloylglucose; Two dimensional gel electrophoresis

Indexed keywords

ACICLOVIR; COFILIN 1; GLUCOSE PENTAGALLATE; MESSENGER RNA; SMALL INTERFERING RNA; VIRUS DNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DOWN REGULATION; DRUG MECHANISM; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; INFECTION PREVENTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; COFILIN 1; DOWN-REGULATION; GENE KNOCKDOWN TECHNIQUES; HERPESVIRUS 1, HUMAN; HUMANS; HYDROLYZABLE TANNINS; RNA, SMALL INTERFERING; VIRUS INTERNALIZATION;

HERPESVIRIDAE; HUMAN HERPESVIRUS 1;

EID: 78650862487     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2010.11.012     Document Type: Article

References (53)

1. Antrobus R., Grant K., Gangadharan B., Chittenden D., Everett R.D., Zitzmann N., Boutell C. Proteomic analysis of cells in the early stages of herpes simplex virus type-1 infection reveals widespread changes in the host cell proteome. Proteomics 2009, 9:3913-3927.
2. Bettinger B.T., Gilbert D.M., Amberg D.C. Opinion-actin up in the nucleus. Nat. Rev. Mol. Cell Biol. 2004, 5:410-415.
3. Bhimani R.S., Troll W., Grunberger D., Frenkel K. Inhibition of oxidative stress in Hela cells by chemopreventive agents. Cancer Res. 1993, 53:4528-4533.
4. Brown S.S. Cooperation between microtubule- and actin-based motor proteins. Annu. Rev. Cell Dev. Biol. 1999, 15:63-80.
5. Cheng H.Y., Lin C.C., Lin T.C. Antiherpes simplex virus type 2 activity of casuarinin from the bark of Terminalia arjuna Linn. Antiviral Res. 2002, 55:447-455.
6. Clement C., Tiwari V., Scanlan P.M., Valyi-Nagy T., Yue B., Shukla D. A novel role for phagocytosis-like uptake in herpes simplex virus entry. J. Cell Biol. 2006, 174:1009-1021.
7. Coen D.M., Schaffer P.A. Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets. Nat. Rev. Drug Discov. 2003, 2:278-288.
8. Danve-Szatanek C., Aymard M., Thouvenot D., Morfin F., Agius G., Bertin I., Billaudel S., Chanzy B., Coste-Burel M., Finkielsztejn L., Fleury H., Hadou T., Henquell C., Lafeuille H., Lafon M.E., Le Faou A., Legrand M.C., Maille L., Mengelle C., Morand P., Morinet F., Nicand E., Omar S., Picard B., Pozzetto B., Puel J., Raoult D., Scieux C., Segondy M., Seigneurin J.M., Teyssou R., Zandotti C. Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up. J. Clin. Microbiol. 2004, 42:242-249.
9. de Lanerolle P., Johnson T., Hofmann W.A. Actin and myosin I in the nucleus: what next?. Nat. Struct. Mol. Biol. 2005, 12:742-746.
10. Dohner K., Nagel C.H., Sodeik B. Viral stop-and-go along microtubules: taking a ride with dynein and kinesins. Trends Microbiol. 2005, 13:320-327.
11. Duan D.L., Li Z.Q., Luo H.P., Zhang W., Chen L.R., Xu X.J. Antiviral compounds from traditional Chinese medicines Galla Chinese as inhibitors of HCV NS3 protease. Bioorg. Med. Chem. Lett. 2004, 14:6041-6044.
12. Favoreel H.W., Enquist L.W., Feierbach B. Actin and Rho GTPases in herpesvirus biology. Trends Microbiol. 2007, 15:426-433.
13. Feierbach B., Piccinotti S., Bisher M., Denk W., Enquist L.W. Alpha-herpesvirus infection induces the formation of nuclear actin filaments. PLoS Pathog. 2006, 2:e85.
14. Frobert E., Cortay J.C., Ooka T., Najioullah F., Thouvenot D., Lina B., Morfin F. Genotypic detection of acyclovir-resistant HSV-1: characterization of 67 ACV-sensitive and 14 ACV-resistant viruses. Antiviral Res. 2008, 79:28-36.
15. Ge F., Lu X.P., Zeng H.L., He Q.Y., Xiong S., Jin L., He Q.Y. Proteomic and functional analyses reveal a dual molecular mechanism underlying arsenic-induced apoptosis in human multiple myeloma cells. J. Proteome Res. 2009, 8:3006-3019.
16. Gouin E., Welch M.D., Cossart P. Actin-based motility of intracellular pathogens. Curr. Opin. Microbiol. 2005, 8:35-45.
17. Ho H.Y., Cheng M.L., Weng S.F., Leu Y.L., Chiu D.T.Y. Antiviral effect of epigallocatechin gallate on Enterovirus 71. J. Agric. Food Chem. 2009, 57:6140-6147.
18. Ho L.L., Chen W.J., Lin-Shiau S.Y., Lin J.K. Penta-O-galloyl-beta-d-glucose inhibits the invasion of mouse melanoma by suppressing metalloproteinase-9 through down-regulation of activator protein-1. Eur. J. Pharmacol. 2002, 453:149-158.
19. Honess R.W., Roizman B. Regulation of herpesvirus macromolecular-synthesis. 1. Cascade regulation of synthesis of 3 groups of viral proteins. J. Virol. 1974, 14:8-19.
20. Hu H.B., Chai Y.B., Wang L., Zhang J.H., Lee H.J., Kim S.H., Lu J.X. Pentagalloylglucose induces autophagy and caspase-independent programmed deaths in human PC-3 and mouse TRAMP-C2 prostate cancer cells. Mol. Cancer Ther. 2009, 8:2833-2843.
21. Isaacs C.E., Wen G.Y., Xu W., Jia J.H., Rohan L., Corbo C., Di Maggio V., Jenkins E.C., Hillier S. Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus. Antimicrob. Agents Chemother. 2008, 52:962-970.
22. Jassim S.A.A., Naji M.A. Novel antiviral agents: a medicinal plant perspective. J. Appl. Microbiol. 2003, 95:412-427.
23. Lee S.J., Lee H.K., Jung M.K., Mar W. In vitro antiviral activity of 1,2,3,4,6-penta-O-galloyl-beta-d-glucose against hepatitis B virus. Biol. Pharm. Bull. 2006, 29:2131-2134.
24. Levy J.A. Three new human herpesviruses (HHV6, 7, and 8). Lancet 1997, 349:558-563.
25. Lyman M.G., Enquist L.W. Herpesvirus interactions with the host cytoskeleton. J. Virol. 2009, 83:2058-2066.
26. Maul G.G., Ishov A.M., Everett R.D. Nuclear domain 10 as preexisting potential replication start sites of herpes simplex virus type-1. Virology 1996, 217:67-75.
27. Meshulam T., Levitz S.M., Christin L., Diamond R.D. A simplified new assay for assessment of fungal cell-damage with the tetrazolium dye, (2,3)-bis-(2-methoxy-4-nitro-5-sulfenyl)-(2H)-tetrazolium-5-carboxanilid E (XTT). J. Infect. Dis. 1995, 172:1153-1156.
28. Mettenleiter T.C. Herpesvirus assembly and egress. J. Virol. 2002, 76:1537-1547.
29. Mettenleiter T.C., Klupp B.G., Granzow H. Herpesvirus assembly: a tale of two membranes. Curr. Opin. Microbiol. 2006, 9:423-429.
30. Morfin F., Thouvenot D. Herpes simplex virus resistance to antiviral drugs. J. Clin. Virol. 2003, 26:29-37.
31. Oriolo A.S., Wald F.A., Ramsauer V.P., Salas P.J.I. Intermediate filaments: a role in epithelial polarity. Exp. Cell Res. 2007, 313:2255-2264.
32. Palamara A.T., Nencioni L., Aquilano K., De Chiara G., Hernandez L., Cozzolino F., Ciriolo M.R., Garaci E. Inhibition of influenza A virus replication by resveratrol. J. Infect. Dis. 2005, 191:1719-1729.
33. Pederson T., Aebi U. Nuclear actin extends, with no contraction in sight. Mol. Biol. Cell 2005, 16:5055-5060.
34. Pollard T.D., Borisy G.G. Cellular motility driven by assembly and disassembly of actin filaments. Cell 2003, 112:453-465.
35. Radtke K., Döhner K., Sodeik B. Viral interactions with the cytoskeleton: a hitchhiker's guide to the cell. Cell. Microbiol. 2006, 8:387-400.
36. Sakai Y., Nagase H., Ose Y., Kito H., Sato T., Kawai M., Mizuno M. Inhibitory action of peony root extract on the mutagenicity of benzo[a]pyrene. Mutat. Res. 1990, 244:129-134.
37. Schumacher D., Tischer B.K., Trapp S., Osterrieder N. The protein encoded by the US3 orthologue of Marek's disease virus is required for efficient de-envelopment of perinuclear virions and involved in actin stress fiber breakdown. J. Virol. 2005, 79:3987-3997.
38. Serkedjieva J., Hay A.J. In vitro anti-influenza virus activity of a plant preparation from Geranium sanguineum L. Antiviral Res. 1998, 37:121-130.
39. Serkedjieva J., Ivancheva S. Antiherpes virus activity of extracts from the medicinal plant Geranium sanguineum L. J. Ethnopharmacol. 1999, 64:59-68.
40. Simpson-Holley M., Baines J., Roller R., Knipe D.M. Herpes simplex virus 1 U(L)31 and U(L)34 gene products promote the late maturation of viral replication compartments to the nuclear periphery. J. Virol. 2004, 78:5591-5600.
41. Simpson-Holley M., Colgrove R.C., Nalepa G., Harper J.W., Knipe D.M. Identification and functional evaluation of cellular and viral factors involved in the alteration of nuclear architecture during herpes simplex virus 1 infection. J. Virol. 2005, 79:12840-12851.
42. Skepper J.N., Whiteley A., Browne H., Minson A. Herpes simplex virus nucleocapsids mature to progeny virions by an envelopment→deenvelopment→reenvelopment pathway. J. Virol. 2001, 75:5697-5702.
43. Smith G.A., Enquist L.W. Break ins and break outs: viral interactions with the cytoskeleton of mammalian cells. Annu. Rev. Cell Dev. Biol. 2002, 18:135-161.
44. Sodeik B., Ebersold M.W., Helenius A. Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus. J. Cell Biol. 1997, 136:1007-1021.
45. Stevens J.M., Galyov E.E., Stevens M.P. Actin-dependent movement of bacterial pathogens. Nat. Rev. Microbiol. 2006, 4:91-101.
46. Turcotte S., Letellier J., Lippe R. Herpes simplex virus type 1 capsids transit by the trans-Golgi network, where viral glycoproteins accumulate independently of capsid egress. J. Virol. 2005, 79:8847-8860.
47. Van Minnebruggen G., Favoreel H.W., Jacobs L., Nauwynck H.J. Pseudorabies virus US3 protein kinase mediates actin stress fiber breakdown. J. Virol. 2003, 77:9074-9080.
48. Wang X.Y., Jia W., Zhao A.H., Wang X.R. Anti-influenza agents from plants and traditional Chinese medicine. Phytother. Res. 2006, 20:335-341.
49. Whitley R.J., Roizman B. Herpes simplex virus infections. Lancet 2001, 357:1513-1518.
50. Xu J., Wang J., Deng F., Hu Z.H., Wang H.L. Green tea extract and its major component epigallocatechin gallate inhibits hepatitis B virus in vitro. Antiviral Res. 2008, 78:242-249.
51. Yeo S.J., Yun Y.J., Lyu M.A., Woo S.Y., Woo E.R., Kim S.J., Lee H.J., Park H.K., Kook Y.H. Respiratory syncytial virus infection induces matrix metalloproteinase-9 expression in epithelial cells. Arch. Virol. 2002, 147:229-242.
52. Yoder A., Yu D.Y., Dong L., Iyer S.R., Xu X.H., Kelly J., Liu J., Wang W.F., Vorster P.J., Agulto L., Stephany D.A., Cooper J.N., Marsh J.W., Wu Y.T. HIV envelope-CXCR4 signaling activates cofilin to overcome cortical actin restriction in resting CD4 T cells. Cell 2008, 134:782-792.
53. Zhang Y.J., Abe T., Tanaka T., Yang C.R., Kouno I. Phyllanemblinins A-F, new ellagitannins from Phyllanthus emblica. J. Nat. Prod. 2001, 64:1527-1532.